Dario selected as digital therapeutics partner by a top-ten digitally enabled pharmacy benefits manager

New agreement is the first contract resulting from strategic partnership with sanofi new york , march 27, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital therapeutics (dtx) market, announced a new contract with a leading nationwide pharmacy benefits manager (the "pbm") operating in 50 states to provide dario's digital therapeutics, starting with the diabetes solution, to employer clients beginning in the second quarter of 2023.   through the new contract, the pbm will replace an existing digital diabetes solution with dario's proven cardio metabolic digital therapeutic.
DRIO Ratings Summary
DRIO Quant Ranking